Medicinal product contracts with accession option
BARMER Beschaffung und Vergabe, WuppertalTED 725664-2026
value not stated4 lots
Wed 1 Nov12:00 in Berlin
734days
Public tenders in Germany
7,249 open tenders
CountryTenderValueClosesDays left
Conclusion of a non-exclusive discount agreement pursuant to § 130a Abs. 8 SGB V for the active substance Guanfacine, ATC N06BA21 for the period 01.01.2026 - 31.12.2027 (including extension option 1x12 months)
DAK-Gesundheit, HamburgTED 763927-2025
€11 lot, 2 years
Sun 5 Nov12:00 in Berlin
738days
Conclusion of a non-exclusive discount agreement pursuant to § 130a para. 8 of the German Social Code Book V (SGB V) for the active substance Pazopanib, ATC L01EX03, for the period 01.01.2026 – 31.12.2027 (plus extension option 1x12 months)
DAK-Gesundheit, HamburgTED 762182-2025
€11 lot, 2 years
Sun 5 Nov12:00 in Berlin
738days
Conclusion of a non-exclusive discount agreement pursuant to § 130a Abs. 8 SGB V for the active substance Abiraterone (excluding strength 500mg), ATC L02BX03 for the period 01.10.26 - 31.12.27 (including extension option 1x12 months)
DAK-Gesundheit, HamburgTED 571201-2026
€11 lot, 15 months
Sun 5 Nov12:00 in Berlin
738days
Conclusion of Non-Exclusive Discount Agreements Pursuant to Section 130 a Paragraph 8 of Book V of the Social Code, Effective from 01.01.2027
GWQ ServicePlus AG, DüsseldorfTED 739900-2026
value not stated23 lots
Fri 10 Nov10:00 in Berlin
743days
Conclusion of a non-exclusive discount agreement pursuant to Section 130a Paragraph 8 of the Fifth Book of the German Social Code (SGB V) for the active substance Filgrastim, ATC L03AA02, for the period 01.01.2027 – 31.12.2027 (plus extension option of 1 × 12 months)
DAK-Gesundheit, HamburgTED 720158-2026
€11 lot, 1 year
Sun 19 Nov12:00 in Berlin
752days
Conclusion of a non-exclusive discount agreement pursuant to Section 130a Paragraph 8 of the Fifth Book of the German Social Code (SGB V) for the active substance Pegfilgrastim, ATC L03AA13, for the period 01.01.2027 – 31.12.2027 (plus extension option of 1 × 12 months)
DAK-Gesundheit, HamburgTED 720012-2026
€11 lot, 1 year
Sun 19 Nov12:00 in Berlin
752days
Training Services in Languages (Open House)
Deutsches Zentrum für Luft- und Raumfahrt e.V. (DLR), KölnTED 291336-2026
€1,200,0001 lot
Thu 30 Nov08:00 in Berlin
763days
Training Services in Project Management at Open House
Deutsches Zentrum für Luft- und Raumfahrt e.V. (DLR), KölnTED 291425-2026
€1,500,0001 lot
Thu 30 Nov08:00 in Berlin
763days
Open House biologics rebate contracts 2026 - 29 rituximab (finished medicinal products only)
Techniker Krankenkasse, HamburgTED 707429-2026
value not stated1 lot
Thu 30 Nov23:58 in Berlin
763days
Open-house discount agreements 2026-18
Techniker Krankenkasse, HamburgTED 742945-2026
value not stated10 lots
Thu 30 Nov23:58 in Berlin
763days
Conclusion of a non-exclusive pharmaceutical discount agreement pursuant to § 130a para. 8 SGB V under an open-house model for the active substance Apixaban (WHO ATC Code: B01AF02)
AOK PLUS - Die Gesundheitskasse für Sachsen und Thüringen, ErfurtTED 672860-2026
value not stated1 lot
Thu 30 Nov23:58 in Berlin
763days
Conclusion of a non-exclusive medicinal product discount agreement pursuant to Section 130a Paragraph 8 of the Fifth Book of the German Social Code (SGB V) under an open-house model for the active substance Pancreatin (WHO ATC Code: A09AA02)
AOK PLUS - Die Gesundheitskasse für Sachsen und Thüringen, ErfurtTED 718722-2026
value not stated1 lot
Thu 30 Nov23:58 in Berlin
763days
Open House Original Discount Agreements 2024-10 – Tiotropium Bromide (Spiriva(R) Respimat, ATC: R03BB04)
Techniker Krankenkasse, HamburgTED 685248-2026
value not stated1 lot
Thu 30 Nov23:58 in Berlin
763days
Open-House-Originale Discount Agreements 2026-14 Crizotinib
Techniker Krankenkasse, HamburgTED 693690-2026
value not stated1 lot
Thu 30 Nov23:58 in Berlin
763days
Open-house discount contracts 2026-17 Tafamidis
Techniker Krankenkasse, HamburgTED 724203-2026
value not stated3 lots
Thu 30 Nov23:58 in Berlin
763days
Conclusion of a non-exclusive discount agreement under § 130a, paragraph 8, SGB V for the active substance Everolimus, ATC L04AH02 for the period 01.02.2026 - 31.01.2028 (including extension option 1x12 months)
DAK-Gesundheit, HamburgTED 832234-2025
€11 lot, 2 years
Tue 5 Dec12:00 in Berlin
768days
Conclusion of a non-exclusive discount agreement under § 130a Abs. 8 SGB V for the active substance Desvenlafaxin, ATC N06AX23 for the period 01.02.2026 - 31.01.2028 (including extension option 1x12 months)
DAK-Gesundheit, HamburgTED 830952-2025
€11 lot, 2 years
Tue 5 Dec12:00 in Berlin
768days
Conclusion of a non-exclusive discount agreement under § 130a Abs. 8 SGB V for the active substance Progesteron (excluding Dafo. WKA), ATC G03DA04 for the period 01.02.26 - 31.01.28 (including V.-option 1x12 months)
DAK-Gesundheit, HamburgTED 830300-2025
€11 lot, 2 years
Tue 5 Dec12:00 in Berlin
768days
Conclusion of a non-exclusive discount agreement under § 130a Abs. 8 SGB V for the active substance Prednisolone, ATC S01BA04 for the period 01.02.2026 - 31.01.2028 (including extension option 1x12 months)
DAK-Gesundheit, HamburgTED 830981-2025
€11 lot, 2 years
Tue 5 Dec12:00 in Berlin
768days
SIMAP: This is not an official publication. The data published on www.simap.ch are authoritative. SIMAP data use is subject to its terms.